- Home
- PRGO vs NXRT Comparison
PRGO vs NXRT Comparison
Compare PRGO & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- NXRT
- Stock Information
- Founded
- PRGO 1887
- NXRT 2014
- Country
- PRGO Ireland
- NXRT United States
- Employees
- PRGO N/A
- NXRT N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- NXRT Real Estate Investment Trusts
- Sector
- PRGO Health Care
- NXRT Real Estate
- Exchange
- PRGO Nasdaq
- NXRT Nasdaq
- Market Cap
- PRGO 3.9B
- NXRT 1.2B
- IPO Year
- PRGO 1991
- NXRT N/A
- Fundamental
- Price
- PRGO $25.76
- NXRT $42.45
- Analyst Decision
- PRGO Buy
- NXRT Buy
- Analyst Count
- PRGO 4
- NXRT 5
- Target Price
- PRGO $37.00
- NXRT $49.00
- AVG Volume (30 Days)
- PRGO 1.2M
- NXRT 96.7K
- Earning Date
- PRGO 11-06-2024
- NXRT 02-18-2025
- Dividend Yield
- PRGO 4.29%
- NXRT 4.80%
- EPS Growth
- PRGO N/A
- NXRT 54.64
- EPS
- PRGO N/A
- NXRT 1.77
- Revenue
- PRGO $4,392,000,000.00
- NXRT $264,974,000.00
- Revenue This Year
- PRGO N/A
- NXRT N/A
- Revenue Next Year
- PRGO $4.51
- NXRT $0.54
- P/E Ratio
- PRGO N/A
- NXRT $24.01
- Revenue Growth
- PRGO N/A
- NXRT N/A
- 52 Week Low
- PRGO $23.89
- NXRT $28.20
- 52 Week High
- PRGO $34.60
- NXRT $48.37
- Technical
- Relative Strength Index (RSI)
- PRGO 36.42
- NXRT 35.23
- Support Level
- PRGO $25.16
- NXRT $45.38
- Resistance Level
- PRGO $28.62
- NXRT $46.15
- Average True Range (ATR)
- PRGO 0.66
- NXRT 1.24
- MACD
- PRGO -0.35
- NXRT -0.57
- Stochastic Oscillator
- PRGO 15.79
- NXRT 23.86
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.